Disclosures for "Modeling of Aryl Hydrocarbon Receptor Pathway Intrinsic Immunometabolic Role using Glioblastoma Stem Cells and Patient-Derived Organoids")
-
Fumihiro Watanabe has nothing to disclose.
-
Ethan Hollingsworth has nothing to disclose.
-
Dr. Bartley has nothing to disclose.
-
Paula Schiapparelli has nothing to disclose.
-
Alfredo Quiñones-Hinojosa has nothing to disclose.
-
Dr. Imitola has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . The institution of Dr. Imitola has received research support from biogen. Dr. Imitola has a non-compensated relationship as a Board Member with National MS Society that is relevant to AAN interests or activities. Dr. Imitola has a non-compensated relationship as a Committee Member with International Society for Stem Cell Research that is relevant to AAN interests or activities.